Cytocell Ltd. recalls Aquarius D13S319 Plus Deletion Probe, Model LPH068-A Product Usage: The D13S319 probe, labelled in red, covers a 156kb…
- Recall date
- April 26, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1843-2019
- FDA classification
- Class III
- Brand / firm
- Cytocell Ltd.
- Sold / distributed
- Worldwide Distribution - US Nationwide AL, CO, FL, HI, IA, IL, IN, KY, MA, MD, MI, MO, MS, NC, NJ, NY, TN, TX, UT, WA, and WI. The products were distributed to the following foreign countries: Canada.
Why it was recalled
There is an error in the chromomap on the package insert.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Aquarius D13S319 Plus Deletion Probe, Model LPH068-A Product Usage: The D13S319 probe, labelled in red, covers a 156kb region including most of the DLEU2 gene, part of the DLEU1 gene and the D13S319 and D13S272 markers. The 13qter subtelomere specific probe, labelled in green, allows identification of chromosome 13 and acts as a control probe.
Get recall alerts
Free email alert whenever Cytocell Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cytocell Ltd.